Hepatitis B associated liver failure following bone marrow transplantation

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 572-577

  Caselitz, M ^a   Link, H ^a   Hein, R ^a   Maschek, H ^a   Boker K ^a   Poliwoda, H ^a   Manns, M P ^a  

^a NONE

Author keywords

Adoptive immune transfer; Bone marrow transplantation; Hepatitis B; Immunosuppression; Liver failure

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOPTIVE TRANSFER; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RISK; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE ASSOCIATION; GRAFT VERSUS HOST REACTION; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; LIVER FAILURE; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0030863951     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80363-7     Document Type: Article

References (14)

1. Chen PM, Fan S, Liu CJ, Hsieh RK, Liu JH, Chuang MW, et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation. 49:1990;708-713.
2. Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology. 104:1993;1818-1821.
3. Lok AH, Liang RH, Chung HT. Recovery of chronic hepatitis B (letter). Ann Intern Med. 116:1992;957-958.
4. Reed EC, Myerson D, Corey L, Meyers JD. Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. Blood. 77:1991;195-200.
5. Pariente EA, Goudeau A, Dubois F, Degott C, Gluckman E, Devergie A, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci. 33:1988;1185-1191.
6. Hoofnagle JH, Dusheiko GM, Schafer DF, Jones A, Micetich K, Young RC, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med. 96:1982;447-449.
7. HL Tillmann, Trautwein C, Waker D, Mitichitaka K, Kubicka S, Böker KHW, et al. Clinical relevance of mutations in the precore Genome of the hepatitis B virus. Gut. 37:1995;568-573.
8. Locasciulli A, Bacigalupo A, Van-Lint MT, Chemello L, Pontisso P, Occhini D, et al. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant. 6:1990;25-29.
9. Webster A, Brenner MK, Prentice HG, Griffiths PD. Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transplant. 4:((2)):1989;207-208.
10. Kanamori H, Fukawa H, Maruta A, Harano H, Kodama F, Matsuzaki M, et al. Case report: fulminant hepatitis C viral infection after allogenic bone marrow transplantation. Am J Med Sci. 303:((2)):1992;109-111.
11. Rakela J, Redecker AG, Weliky B. Effect of short term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology. 84:1983;956-960.
12. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis. Gastroenterology. 81:1981;987-991.
13. Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med. 323:1990;705-712.
14. Sinclair SB, Greig PD, Blendis LM, Abecassis EA, Roberts EA, Philipps MJ, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J Clin Invest. 84:1989;1063-1069.